# US 8,198,085 B2 · Somatic cells for use in cell therapy

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 8,198,085 B2
- Document ID: US8198085B2
- Status: Granted
- Kind: B2
- Application number: 11/989,929
- Filed: 2006-08-03
- Published: 2010-04-29
- Granted: 2012-06-12
- Earliest claimed: 2005-08-03
- Assignees: Core Dynamics Limited
- Inventors: Tamir Kanias; Yehudit Natan
- Web page: https://patentgrep.com/patent/US8198085B2

## CPC

- A01N 1/10: Preservation of living parts
- A01N 1/125: Freeze protecting agents, e.g. cryoprotectants or osmolarity regulators
- A61K 35/28: Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
- A61K 35/545: Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The present invention generally concerns cell therapy and products for use in such therapy. Particularly, the invention provides a preserved cell preparation essentially free of one or more members of a group of cryoprotecting agents consisting of polyalcohols, DMSO and cryoprotecting proteins, the preserved cell preparation comprising somatic cells and at least one polyphenol, wherein upon reconstitution of cells in the cell preparation, at least a portion of said stem cells are viable, said portion being sufficient for use of the cell preparation in stem cell therapy. The invention also provides cells reconstituted from preserved somatic cells, and the use of the reconstituted cells in cell therapy. A preferred cell preparation in accordance with the invention comprises stem cells, preferably human stem cells.

## Claims

### Claim 1

A preserved cell preparation, comprising:
lyophilized cells; and
at least one polyphenol selected from the group consisting of epigallocatechin gallate (EGCG), epicatechin gallate (ECG), epigallocatechin (EGC), epicatechin (EC), DL-Catechin (DL-C) and gallocatechin gallate (GCG), or mixtures thereof, the polyphenol being present in a concentration of from about 50 μM to about 4 mM,
the preserved cell preparation being essentially free of one or more cryoprotecting agents selected from the group consisting of polyalcohols, DMSO and cryoprotecting proteins, and
upon reconstitution of the preserved cell preparation, at least 60% of the lyophilized cells in the preserved cell preparation are viable and sufficient for use in cell therapy.

### Claim 2 (depends on 1)

The preserved cell preparation of claim 1, wherein the polyphenol is EGCG.

### Claim 3 (depends on 2)

The preserved cell preparation of claim 2, further comprising trehalose.

### Claim 4 (depends on 1)

The preserved cell preparation of claim 1, wherein the lyophilized cells are obtained by cooling cells at a cooling rate of 5.1° C./min.

### Claim 5 (depends on 3)

The preserved cell preparation of claim 3, obtainable by freezing cells to obtain frozen cells and then freeze drying the frozen cells to obtain the preserved cell preparation.

### Claim 6 (depends on 1)

The preserved cell preparation of claim 1, wherein the lyophilized cells comprise stem cells selected from the group consisting of hematopoietic stem cells, embryonic stern cells, embryonic germ cells and mesenchymal stem cells.

### Claim 7 (depends on 1)

The preserved cell preparation of claim 1, wherein the lyophilized cells comprise human stem cells.
